Are Costs for Medical Cannabis Reimbursed?
Five states, including New York and New Jersey, currently permit injured workers to receive post-purchase medical cannabis reimbursement through Workers’ Compensation Insurance, while six others explicitly prohibit it.
You might assume that health insurance covers medical cannabis costs, but unfortunately, that is rarely the case. Standard health insurance plans generally do not pay for medical marijuana, even in states where its use is fully legal.
However, a select number of legal states permit eligible patients to receive reimbursement for medical cannabis expenses through Workers’ Compensation Insurance (WCI) plans. Read on to learn how medical cannabis reimbursement works across the U.S.
Why Health Insurers Deny Medical Cannabis Coverage
The main barrier to standard health insurance coverage is that cannabis sold through state-licensed dispensaries is not an FDA-approved prescription drug. Although federal policy has shifted, including the Justice Department’s April 2026 decision to place state-licensed medical marijuana in Schedule III, dispensary cannabis remains outside the conventional prescription-drug system.
Because healthcare providers issue certification recommendations rather than standard prescriptions for botanical medical cannabis, commercial health insurers and federal programs like Medicare generally do not cover standard pharmacy claims for raw plant material, tinctures, or edibles.
Key barriers to health insurance coverage include:
- Prescription vs. Recommendation: Physicians cannot write formal “prescriptions” for unapproved botanical cannabis; they can only issue state-level “recommendations.”
- Formulary Exclusion: Insurers only cover drugs listed on a health plan formulary, which is a requirement botanical cannabis has not yet met.
- Lack of FDA approval: Botanical cannabis flower or other medicinal extracts have not completed clinical trial pathways required for standard pharmacy distribution.
Will Federal Rescheduling Change Insurance Coverage?
Federal cannabis policy has already shifted, but the changes do not automatically translate into health insurance coverage. As of April 2026, the U.S. Department of Justice placed FDA-approved marijuana products and state-licensed medical marijuana in Schedule III under the Controlled Substances Act. A separate DEA proceeding is considering broader rescheduling of marijuana, but that process has not yet been finalized.
Even broader Schedule III rescheduling would not automatically require health insurers to cover dispensary cannabis. It would change cannabis’s federal classification but would not make state-dispensary products FDA-approved prescription drugs or require insurers to add them to their formularies.
For a cannabis-based product to gain standard health insurance coverage, it would generally need to meet the requirements that apply to prescription medicines:
- FDA Marketing Approval: A product would generally need FDA approval based on evidence establishing its safety, efficacy, quality, and appropriate use for specific medical indications.
- Formulary Inclusion: Once approved, a drug would typically need to be evaluated for inclusion in a health plan’s formulary. Coverage would still depend on the individual insurer or government program and could involve restrictions such as prior authorization or quantity limits.
- Pharmaceutical Distribution: FDA-approved cannabis-based medicines would generally enter the conventional prescription-drug supply chain rather than being purchased as state-regulated dispensary products.
As a result, broader federal rescheduling could remove some legal and regulatory barriers for the cannabis industry, but it would not by itself create a pathway to automatic insurance reimbursement for whole-plant cannabis or other products purchased at dispensaries. Meaningful changes to coverage would likely require FDA-approved products, insurer or government-program decisions, or specific legislative mandates.
Seniors are one of the fastest-growing groups of cannabis consumers. But what’s driving the shift, and how are older adults using cannabis today? This video takes a closer look. Video source: CBS Evening News via YouTube
FDA-Approved Cannabinoid Exception
A small number of FDA-approved cannabinoid medications can be prescribed by physicians and may be covered by commercial health insurance or Medicare Part D, depending on the specific plan and its formulary requirements. Unlike cannabis purchased through state-licensed dispensaries, these medications have undergone the FDA approval process and are regulated as prescription drugs:
- Epidiolex: The plant-derived purified cannabidiol (CBD) oral solution approved for treating severe seizure disorders (Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex).
- Marinol & Syndros (Dronabinol): The synthetic delta-9-THC formulations approved for nausea associated with cancer chemotherapy and anorexia associated with AIDS weight loss.
- Cesamet (Nabilone): A synthetic cannabinoid approved for nausea and vomiting associated with cancer chemotherapy, particularly when conventional antiemetics have not provided adequate relief.
Workers’ Compensation Insurance: A State-by-State Exception
Unlike standard health insurance, workers’ compensation is governed largely by state-specific laws and court decisions, creating a limited pathway for reimbursement of medical cannabis in some jurisdictions.
A small number of states allow or require workers’ compensation insurers to reimburse injured workers for medical cannabis expenses, generally when the treatment is considered reasonable and necessary for a work-related injury. In other states, laws or court decisions expressly prevent workers’ compensation insurers from covering cannabis.
The states with established positions include:
- Reimbursed or Allowed: Connecticut, New Hampshire, New Jersey, New Mexico, and New York have laws or judicial decisions supporting workers’ compensation reimbursement for medical cannabis under certain circumstances.
- Prohibited: Florida, Maine, Massachusetts, North Dakota, Ohio, and Washington have laws or judicial decisions prohibiting workers’ compensation reimbursement for medical marijuana.
- Other Jurisdictions: In many other states, the law is less clear, does not require reimbursement, or leaves the issue subject to interpretation by courts or workers’ compensation authorities.
Even where reimbursement is permitted, it generally does not mean that cannabis is covered upfront like a conventional prescription drug. Injured workers may need to pay for their medical cannabis themselves and seek reimbursement afterward, subject to the applicable state rules and any medical-necessity requirements.
For most patients purchasing cannabis through state-licensed dispensaries, therefore, out-of-pocket payment remains the norm. Broader insurance coverage would likely require further legislative, regulatory, or judicial changes at the state or federal level.
Read more from Soft Secrets:
Disclaimer: Cannabis laws and medical guidance vary by jurisdiction. Always check local regulations and consult a qualified healthcare professional before using cannabis for medical purposes.
S
Stephen Andrews
